Park Soon-jae
$2.79B
as of 10/04/24
About Park Soon-jae
Park Soon-jae is cofounder and CEO of South Korean biotechnology company Alteogen, which focuses on biosimilars and bio-betters.
In recent years, Alteogen has been making more money from ALT-B4, a technology that allows drugs to be administered subcutaneously instead of intravenously.
In February 2024, Alteogen revealed Merck had agreed to a licensing deal to use ALT-B4 for the drug giant's cancer drug pembrolizumab. Alteogen shares soared 25% in a day following the announcement.
Park's wife, Chung Hye-shin, who is chief scientific officer of Alteogen, owns a small stake in the company.
Personal stats
Citizenship
South KoreaSource of wealth
BiopharmaceuticalsResidence
Daejeon, South KoreaMarital status
MarriedBirth date
12/22/54 (age 69)Education
Ph.D, Purdue UniversitySelf-made
self-madePark Soon-jae’s fortune is worth
47K
troy ounces of gold
43K
median U.S. household
28K
median U.S. income
0.056%
U.S. credit card volume
0.011%
GDP of the United States
0.008%
United States debt
Related people
Did you know?
Prior to cofounding Alteogen in 2008, Park worked at LG Life Sciences and Hanwha Petrochemical, and was a postdoctoral researcher at MIT.
Net worth over time
Real-time ranking
Financial assets
KOREA | 196170-KR
AlteogenImages © Forbes.com. All rights reserved.